There are relatively few reports detailing the outcome of children and adolescents with arteriovenous malformations (AVMs) treated with stereotactic radiosurgery (SRS). We reviewed our experience over the past decade to determine whether the outcomes and toxicity were similar to those reported in adults. Seventeen patients 18 years of age or younger underwent linear-accelerator-based SRS. The targeted volume was greater than 3 cm3 in 65% of cases (range 0.7–25 cm3; median volume 6.9 cm3). The prescribed radiation doses varied from 16 to 18 Gy, with 70% receiving the highest dose. Using only angiographic data, the obliteration rate was 80% (8 of 10 patients), but using both MRA/MRI and angiographic data, it was 53% (9 of 17 patients). Four patients developed late effects potentially attributable to the radiation between 2 months and 3 years following SRS. One of these was transient and disappeared completely within a few days, but in the other 3 patients, the neurologic sequelae were permanent. Two of the 4 complications appeared to be due to radiation necrosis/edema, whereas the remaining 2 may have been due to vasculopathy. All 4 patients with complications had treatment volumes greater than 5 cm3 (5.4, 6.9, 11.1, 16.4 cm3), all had a prescribed dose of 18 Gy and all had initially presented with an AVM hemorrhage. Linear-accelerator-based SRS is effective in obliterating most AVMs in children; however, the potential for late effects exists, especially for those patients with larger target volumes.

Keywords:
Arteriovenous malformation, Stereotactic radiosurgery
1.
Leksell L: The stereotactic method of radiosurgery of the brain. Acta Chir Scand 1951;102:316–319.
2.
Colombo F, Pozza F, Chierego G, Casentini L, De Luca G, Francescon P: Linear accelerator radiosurgery of cerebral arteriovenous malformations: An update. Neurosurgery 1994;34:14–20; discussion 20–21.
3.
Friedman WA, Bova FJ: Linear accelerator radiosurgery for arteriovenous malformations. J Neurosurg 1992;77:832–841.
4.
Steinberg GK, Fabrikant JI, Marks MP, Levy RP, Frankel KA, Phillips MH, Shuer LM, Silverberg GD: Stereotactic heavy-charged-particle Bragg-peak radiation for intracranial arteriovenous malformations. N Engl J Med 1990;323:96–101.
5.
Niranjan A, Lunsford LD, Gobbel GT, Kondziolka D, Maitz A ,Flickinger JC: Brain tumor radiosurgery: Current status and strategies to enhance the effect of radiosurgery. Brain Tumor Pathol 2000;17:89–96.
6.
Alexander E 3rd, Loeffler JS: The role of radiosurgery for glial neoplasms. Neurosurg Clin N Am 1999;10:351–358.
7.
Friedman WA: Radiosurgery versus surgery for arteriovenous malformations: The case for radiosurgery. Clin Neurosurg 1999;45:18–20.
8.
Lunsford LD, Kondziolka D, Flickinger JC, Bissonette DJ, Jungreis CA, Maitz AH, Horton JA ,Coffey RJ: Stereotactic radiosurgery for arteriovenous malformations of the brain. J Neurosurg 1991;75:512–524.
9.
Steiner L, Lindquist C, Adler JR, Torner JC, Alves W, Steiner M: Clinical outcome of radiosurgery for cerebral arteriovenous malformations. J Neurosurg 1992;77:1–8.
10.
Kjellberg RN, Hanamura T, Davis KR, Lyons SL, Adams RD: Bragg-peak proton-beam therapy for arteriovenous malformations of the brain. N Engl J Med 1983;309:269–274.
11.
Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457–481.
12.
Hladky JP, Lejeune JP, Blond S, Pruvo JP, Dhellemmes P: Cerebral arteriovenous malformations in children: Report on 62 cases. Childs Nerv Syst 1994;10:328–333.
13.
Gerosa MA, Cappellotto P, Licata C, Iraci G, Pardatscher K, Fiore DL: Cerebral arteriovenous malformations in children (56 cases). Childs Brain 1981;8:356–371.
14.
Ondra SL, Troupp H, George ED, Schwab K: The natural history of symptomatic arteriovenous malformations of the brain: A 24-year follow-up assessment. J Neurosurg 1990;73:387–391.
15.
Wilkins RH: Natural history of intracranial vascular malformations: A review. Neurosurgery 1985;16:421–430.
16.
Mori K, Murata T, Hashimoto N, Handa H: Clinical analysis of arteriovenous malformations in children. Childs Brain 1980;6:13–25.
17.
Humphreys RP, Hoffman HJ, Drake JM, Rutka JT: Choices in the 1990s for the management of pediatric cerebral arteriovenous malformations. Pediatr Neurosurg 1996;25:277–285.
18.
Celli P, Ferrante L, Palma L, Cavedon G: Cerebral arteriovenous malformations in children. Clinical features and outcome of treatment in children and in adults. Surg Neurol 1984;22:43–49.
19.
Fong D, Chan ST: Arteriovenous malformation in children. Childs Nerv Syst 1988;4:199–203.
20.
Levy EI, Niranjan A, Thompson TP, Scarrow AM, Kondziolka D, Flickinger JC, Lunsford LD: Radiosurgery for childhood intracranial arteriovenous malformations. Neurosurgery 2000;47:834–841; discussion 841–842.
21.
Smyth MD, Sneed PK, Ciricillo SF, Edwards MS, Wara WM, Larson DA, Lawton MT, Gutin PH, McDermott MW: Stereotactic radiosurgery for pediatric intracranial arteriovenous malformations: The University of California at San Francisco experience. J Neurosurg 2002;97:48–55.
22.
Yamamoto M, Jimbo M, Ide M, Tanaka N, Lindquist C, Steiner L: Long-term follow-up of radiosurgically treated arteriovenous malformations in children: Report of nine cases. Surg Neurol 1992;38:95–100.
23.
Riva D, Pantaleoni C, Devoti M, Saletti V, Nichelli F, Giorgi C: Late neuropsychological and behavioural outcome of children surgically treated for craniopharyngioma. Childs Nerv Syst 1998;14:179–184.
24.
Nicolato A, Gerosa M, Ferraresi P, Piovan E, Pasoli A, Perini S, Mazza C: Stereotactic radiosurgery for the treatment of arteriovenous malformations in childhood. J Neurosurg Sci 1997;41:359–371.
25.
Miyawaki L, Dowd C, Wara W, Goldsmith B, Albright N, Gutin P, Halbach V, Hieshima G, Higashida R, Lulu B, Pitts L, Schell M, Smith V, Weaver K, Wilson C, Larson D: Five year results of LINAC radiosurgery for arteriovenous malformations: Outcome for large AVMS. Int J Radiat Oncol Biol Phys 1999;44:1089–1106.
26.
St George EJ, Perks J, Plowman PN: Stereotactic radiosurgery XIV: The role of the haemosiderin ‘ring’ in the development of adverse reactions following radiosurgery for intracranial cavernous malformations: A sustainable hypothesis. Br J Neurosurg 2002;16:385–391.
27.
Omura M, Aida N, Sekido K, Kakehi M, Matsubara S: Large intracranial vessel occlusive vasculopathy after radiation therapy in children: Clinical features and usefulness of magnetic resonance imaging. Int J Radiat Oncol Biol Phys 1997;38:241–249.
28.
Maher CO, Raffel C: Early vasculopathy following radiation in a child with medulloblastoma. Pediatr Neurosurg 2000;32:255–258.
29.
Grenier Y, Tomita T, Marymont MH, Byrd S, Burrowes DM: Late postirradiation occlusive vasculopathy in childhood medulloblastoma. Report of two cases. J Neurosurg 1998;89:460–464.
© 2004 S. Karger AG, Basel
2005
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.